webinar

Comparing EMA and Health Canada CTA submission for Phase I trials to US FDA IND application

Supported by:

9 March 2021

Supported by:

9 March 2021

5 responses to “Comparing EMA and Health Canada CTA submission for Phase I trials to US FDA IND application”

  1. Vandana says:

    Hi, How can I watch this webinar?

    • Hannah Balfour says:

      Hi Vandana,
      To watch the webinar simply fill in your details in the registration section and it will take you through to a page where you can watch the video of the webinar.

  2. The post was very informative. Thank you!

  3. The post was very informative. Thank you!

  4. This webinar post helped me a lot. Thank you for your informative inputs.

Leave a Reply

Your email address will not be published. Required fields are marked *